Literature DB >> 2646134

Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.

G Pluschke1, G Bordmann, M E Daoudaki, J D Lambris, M Achtman, M Neibert.   

Abstract

Sequential sublining was used in combination with enzyme-linked immunosorbent assays to isolate mu----gamma isotype switch variants of the rat IgM secreting mouse-rat B cell hybridoma line BA1.8. Switch variants to all four subclasses of IgG were obtained. The variant antibodies retained the antigen specificity of the parental IgM for the O18 (lipopolysaccharide) antigen of Escherichia coli. In sodium dodecyl sulfate-polyacrylamide gels the apparent molecular mass of the gamma heavy chains decreased in the order gamma 2b greater than gamma 1 greater than gamma 2c greater than gamma 2a. IgM, IgG1, IgG2a, IgG2b and IgG2c of the BA1.8 variant family and IgG2b, IgE and IgA of the previously described BA1.2 family were used for a comparative analysis of the capacity of rat Ig to activate complement. Efficient lysis of sheep erythrocytes coated with the O18 antigen was observed with IgM and all IgG subclasses, but no lysis was triggered by IgE or IgA. One hundred to 1000 IgG molecules were required to mediate the same hemolytic activity as one IgM molecule. The four IgG subclasses were equally efficient at mediating lysis by rat or human complement, while IgG2a was less efficient with guinea pig complement than the other three IgG subclasses. Antibody-triggered binding of C3 to pathogenic O18:K1 E. coli bacteria was measured using serum containing 125I-labeled C3. K1-encapsulated strains did not fix C3 efficiently in the absence of specific antibodies while acapsular mutants fixed C3 via the alternative pathway. IgM and all IgG subclasses triggered C3 binding to the K1 encapsulated bacteria. The capacity of IgM to mediate C3 fixation was not greater than that observed with IgG.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646134     DOI: 10.1002/eji.1830190121

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.

Authors:  Terje E Michaelsen; Øistein Ihle; Karen Johanne Beckstrøm; Tove K Herstad; Jan Kolberg; E Arne Høiby; Audun Aase
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras.

Authors:  D Nemazee; K Buerki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Development of an anti-guinea pig CD4 monoclonal antibody for depletion of CD4+ T cells in vivo.

Authors:  Brianne N Banasik; Clarice L Perry; Celeste A Keith; Nigel Bourne; Hubert Schäfer; Gregg N Milligan
Journal:  J Immunol Methods       Date:  2019-08-14       Impact factor: 2.303

4.  Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Haemophilus influenzae Increases Complement-Mediated Killing.

Authors:  Jeroen D Langereis; Eva S van der Pasch; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome.

Authors:  A Ishizaka; K Joh; R Shibata; Y Wagatsuma; M Nakanishi; K Tomizawa; K Kojima; E Kandil; Y Sakiyama; S Matsumoto
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

6.  Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM.

Authors:  L Flores-Romo; M J Millsum; S Gillis; P Stubbs; C Sykes; J Gordon
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

7.  Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.

Authors:  S Pelkonen; G Pluschke
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

Review 8.  Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections.

Authors:  Jeroen D Langereis; Michiel van der Flier; Marien I de Jonge
Journal:  Front Immunol       Date:  2018-08-23       Impact factor: 7.561

Review 9.  Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.

Authors:  Jing Jin; Graham Simmons
Journal:  Viruses       Date:  2019-03-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.